Supplementary Figure S5 from ZSTK3744, a Novel Aryl Hydrocarbon Receptor Agonist, Exhibits Efficacy against Chemotherapy-Resistant Triple-Negative Breast Cancer
Fields of Study & Subjects
Breast Cancer Treatment Studies
Estrogen and related hormone effects
Prostate Cancer Treatment and Research
Publication details
- Publication date
- 27 February 2026
- Language
- EN